Medical Device | May 08, 2026
Microsure secures CE mark for MUSA-3 system, appoints Alex Joseph as CEO
The company plans to collaborate with European medical centres to expand adoption of its robotic microsurgery platform
The company plans to collaborate with European medical centres to expand adoption of its robotic microsurgery platform
With over 30 years of pharmaceutical industry experience, Ponnusamy will lead Alembic’s animal health business strategy, market expansion, and operational growth initiatives
The product is approved as bioequivalent to Xigduo XR for the indications outlined in the reference drug’s labelling
PMDA is regarded among the most stringent regulatory bodies globally
The impact on Phase III trials is particularly significant, as these later-stage studies involve larger, committed patient populations and represent years of investment
The company now offers the complete range of Apomorphine Hydrochloride in different fill volumes
She brings 20 years of in vivo pharmacology experience across academia and industry, including senior scientific and leadership roles at Orion Pharma and Charles River
The Flonase Allergy Relief Nasal Spray, 50 mcg per spray market achieved annual sales of approximately $384.7 million
Glenmark's Milnacipran Hydrochloride Tablets, 12.5 mg, 25 mg, 50 mg, and 100 mg is the authorized generic to Savella Tablets, 12.5 mg, 25 mg, 50 mg, and 100 mg
The product is bioequivalent and therapeutically equivalent to Fresenius Kabi’s reference drug (NDA 212832)
Subscribe To Our Newsletter & Stay Updated
